Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells

Tsuyoshi Nagata, Hisashi Kai, Rei Shibata, Mitsuhisa Koga, Akihiko Yoshimura, Tsutomu Imaizumi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objectives - Matrix metalloproteinase (MMP)-9 is implicated in extracellular matrix (ECM) degradation of atherosclerotic lesions. Oncostatin M (OSM) regulates ECM metabolism in various kinds of cells. Thus, we sought to investigate whether OSM regulates MMP-9 expression in cultured rat aortic smooth muscle cells (SMCs) and, if so, to determine the signaling pathway for MMP-9 induction by OSM. Methods and Results - Competitive reverse transcriptase polymerase chain reaction showed that OSM upregulated MMP-9 mRNA expression, peaking at 4 hours and returning to unstimulated levels by 24 hours. Gelatin zymography revealed that MMP-9 activity was increased in the conditioned medium after the 24-hour OSM treatment. Immunoblot analysis demonstrated that OSM transiently induced extracellular signal-regulated kinase (ERK)1/2 and STAT3 phosphorylations with a peak at 15 and 5 minutes, respectively. A MEK1 inhibitor, PD98059, not only blocked ERK1/2 phosphorylation but also abolished the OSM-induced MMP-9 upregulation, whereas the MMP-9 induction was not affected by overexpressing dominant-negative STAT3. In addition, OSM slightly upregulated MMP-2 and downregulated tissue inhibitors of MMP-1 and -3 through different mechanisms from that in case of MMP-9. Conclusions - OSM upregulates MMP-9 expression in SMCs through the MEK-ERK but not STAT3 pathway.

Original languageEnglish
Pages (from-to)588-593
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume23
Issue number4
DOIs
Publication statusPublished - 2003 Apr 1
Externally publishedYes

Fingerprint

Oncostatin M
Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Matrix Metalloproteinase 9
Smooth Muscle Myocytes
Interleukin-6
Up-Regulation
Cytokines
Extracellular Matrix
Phosphorylation
Matrix Metalloproteinase 3
Matrix Metalloproteinase 1
Tissue Inhibitor of Metalloproteinase-1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Matrix Metalloproteinase 2
Gelatin
Conditioned Culture Medium
Reverse Transcriptase Polymerase Chain Reaction
Down-Regulation

Keywords

  • Matrix metalloproteinase
  • Muscle
  • Oncostatin M
  • Signal transduction
  • Smooth

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{70d60adac028439585f120d694717474,
title = "Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells",
abstract = "Objectives - Matrix metalloproteinase (MMP)-9 is implicated in extracellular matrix (ECM) degradation of atherosclerotic lesions. Oncostatin M (OSM) regulates ECM metabolism in various kinds of cells. Thus, we sought to investigate whether OSM regulates MMP-9 expression in cultured rat aortic smooth muscle cells (SMCs) and, if so, to determine the signaling pathway for MMP-9 induction by OSM. Methods and Results - Competitive reverse transcriptase polymerase chain reaction showed that OSM upregulated MMP-9 mRNA expression, peaking at 4 hours and returning to unstimulated levels by 24 hours. Gelatin zymography revealed that MMP-9 activity was increased in the conditioned medium after the 24-hour OSM treatment. Immunoblot analysis demonstrated that OSM transiently induced extracellular signal-regulated kinase (ERK)1/2 and STAT3 phosphorylations with a peak at 15 and 5 minutes, respectively. A MEK1 inhibitor, PD98059, not only blocked ERK1/2 phosphorylation but also abolished the OSM-induced MMP-9 upregulation, whereas the MMP-9 induction was not affected by overexpressing dominant-negative STAT3. In addition, OSM slightly upregulated MMP-2 and downregulated tissue inhibitors of MMP-1 and -3 through different mechanisms from that in case of MMP-9. Conclusions - OSM upregulates MMP-9 expression in SMCs through the MEK-ERK but not STAT3 pathway.",
keywords = "Matrix metalloproteinase, Muscle, Oncostatin M, Signal transduction, Smooth",
author = "Tsuyoshi Nagata and Hisashi Kai and Rei Shibata and Mitsuhisa Koga and Akihiko Yoshimura and Tsutomu Imaizumi",
year = "2003",
month = "4",
day = "1",
doi = "10.1161/01.ATV.0000060891.31516.24",
language = "English",
volume = "23",
pages = "588--593",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells

AU - Nagata, Tsuyoshi

AU - Kai, Hisashi

AU - Shibata, Rei

AU - Koga, Mitsuhisa

AU - Yoshimura, Akihiko

AU - Imaizumi, Tsutomu

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objectives - Matrix metalloproteinase (MMP)-9 is implicated in extracellular matrix (ECM) degradation of atherosclerotic lesions. Oncostatin M (OSM) regulates ECM metabolism in various kinds of cells. Thus, we sought to investigate whether OSM regulates MMP-9 expression in cultured rat aortic smooth muscle cells (SMCs) and, if so, to determine the signaling pathway for MMP-9 induction by OSM. Methods and Results - Competitive reverse transcriptase polymerase chain reaction showed that OSM upregulated MMP-9 mRNA expression, peaking at 4 hours and returning to unstimulated levels by 24 hours. Gelatin zymography revealed that MMP-9 activity was increased in the conditioned medium after the 24-hour OSM treatment. Immunoblot analysis demonstrated that OSM transiently induced extracellular signal-regulated kinase (ERK)1/2 and STAT3 phosphorylations with a peak at 15 and 5 minutes, respectively. A MEK1 inhibitor, PD98059, not only blocked ERK1/2 phosphorylation but also abolished the OSM-induced MMP-9 upregulation, whereas the MMP-9 induction was not affected by overexpressing dominant-negative STAT3. In addition, OSM slightly upregulated MMP-2 and downregulated tissue inhibitors of MMP-1 and -3 through different mechanisms from that in case of MMP-9. Conclusions - OSM upregulates MMP-9 expression in SMCs through the MEK-ERK but not STAT3 pathway.

AB - Objectives - Matrix metalloproteinase (MMP)-9 is implicated in extracellular matrix (ECM) degradation of atherosclerotic lesions. Oncostatin M (OSM) regulates ECM metabolism in various kinds of cells. Thus, we sought to investigate whether OSM regulates MMP-9 expression in cultured rat aortic smooth muscle cells (SMCs) and, if so, to determine the signaling pathway for MMP-9 induction by OSM. Methods and Results - Competitive reverse transcriptase polymerase chain reaction showed that OSM upregulated MMP-9 mRNA expression, peaking at 4 hours and returning to unstimulated levels by 24 hours. Gelatin zymography revealed that MMP-9 activity was increased in the conditioned medium after the 24-hour OSM treatment. Immunoblot analysis demonstrated that OSM transiently induced extracellular signal-regulated kinase (ERK)1/2 and STAT3 phosphorylations with a peak at 15 and 5 minutes, respectively. A MEK1 inhibitor, PD98059, not only blocked ERK1/2 phosphorylation but also abolished the OSM-induced MMP-9 upregulation, whereas the MMP-9 induction was not affected by overexpressing dominant-negative STAT3. In addition, OSM slightly upregulated MMP-2 and downregulated tissue inhibitors of MMP-1 and -3 through different mechanisms from that in case of MMP-9. Conclusions - OSM upregulates MMP-9 expression in SMCs through the MEK-ERK but not STAT3 pathway.

KW - Matrix metalloproteinase

KW - Muscle

KW - Oncostatin M

KW - Signal transduction

KW - Smooth

UR - http://www.scopus.com/inward/record.url?scp=0037389156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037389156&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000060891.31516.24

DO - 10.1161/01.ATV.0000060891.31516.24

M3 - Article

VL - 23

SP - 588

EP - 593

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 4

ER -